Mesenchymal Cell News

Mesenchymal Cell News is an online resource that delivers updates on the latest research in the mesenchymal stem cell field.

Subscribe|Follow Us On

Connexin 43-Dependent Mesenchymal Stem Cell Mitochondrial Transfer Activates PGC1α Disrupting Oxidative-Inflammation Axis in Ischemia-Reperfusion Injury

July 21, 2026

[Signal Transduction and Targeted Therapy] Scientists observed that MSCs, specifically BM-MSCs, mitigated mitochondrial dysfunction during the early stages of ischemia-reperfusion injury-related acute kidney injury, leading to reduced inflammation, preventing cellular injury and recovery of renal function.

Targeting and Antioxidant Surface-Engineered Mesenchymal Stromal Cells for Enhanced Erectile Dysfunction Therapy

July 21, 2026

[Nature Communications] Researchers showed that mesenchymal stromal cells surface-engineered with polydopamine nanoparticles conjugated to antibodies against vascular cell adhesion molecule 1 exhibit enhanced retention, survival, and therapeutic efficacy in erectile dysfunction.

Shaping Mesenchymal Stem Cell Fate with a Two-Dimensional Covalent Triazine Framework for Calmodulin Modulation

July 21, 2026

[Biomaterials] Investigators introduced a novel two-dimensional, porous, covalent triazine-based framework, CTF-Ca, synthesized under ambient conditions, that offers a new strategy for intracellular calmodulin regulation.

Mesenchymal Stem Cells Receive Adaptive Islet-Derived-miR-151-Containing sEVs to Promote β Cell Compensation in Obesity

July 21, 2026

[Science Advances] The authors showed that adaptive islet–derived small extracellular vesicles play a key role in β cell adaptation in obesity.

LGR5 As a Therapeutic Target for Decidualization-Based Endometrial Mesenchymal Stem Cells Therapy in Thin Endometrium

July 21, 2026

[Stem Cell Research & Therapy] Researchers found that LGR5 plays an important role in endometrial MSCs decidualization and may contribute to the therapeutic efficacy of decidualized endometrial MSCs for thin endometrium repair, potentially through regulation of PGR via the β-catenin pathway.

Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Muscle Dysfunction and Metabolic Dysregulation in the CuZnSOD Null Mouse Model of Sarcopenia

July 21, 2026

[Experimental Gerontology] Scientists investigated whether systemic administration of human umbilical cord–derived MSCs could modulate muscle function and metabolic homeostasis under both pathological and physiological conditions.

Therapeutic Potential of Mesenchymal Stem Cells in Multiple Sclerosis: An Updated Review

July 21, 2026

[Molecular Neurobiology] The authors provide an updated overview of the therapeutic potential of MSCs in multiple sclerosis, summarizing key experimental and clinical studies that explore their mechanisms of action, efficacy, and safety profiles across different tissue sources.

MEDIPOST Inc. Treats First US Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis

July 21, 2026

[MEDIPOST Inc. (Business Wire)] MEDIPOST Inc., announced the treatment of the first US participant in its Phase III clinical trial evaluating its investigational MSC therapy to treat symptomatic cartilage defects in adults with knee osteoarthritis.

Endosteal Integrin-α8⁺ Mesenchymal Stem Cells Maintain Hematopoietic Stem Cell Function via Extracellular Matrix-Mediated Interactions

July 7, 2026

[Nature Communications] Scientists identified a distinct subset of MSCs expressing integrin α8 within the bone marrow endosteum. These cells exhibited distinct MSC properties and higher hematopoietic supportive activity than other MSC subsets.

Visible Light Reprograms MSCs and T Cells Into Tumor-Suppressive States via OPN4-Mediated Epigenetic Remodeling

July 7, 2026

[Acta Pharmacologica Sinica] Using mechanical and electrical stimulation as controls, scientists examined optically stimulated MSCs and T cells and their conditioned medium in breast cancer and osteoclast models.

Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes

July 7, 2026

[Stem Cell Reviews and Reports] By integrating insights from T1D immunopathogenesis, MSC biology, genome editing, and translational immunology, the authors propose a framework linking immune engineering with controlled differentiation, functional maturation, and long-term safety evaluation.

A Microgel Bone Marrow Model of Mesenchymal Stromal Cell Paracrine Signaling Supporting Hematopoietic Stem Cell Retention

July 7, 2026

[Acta Biomaterialia] Scientists described a granular biomaterial approach to create a multicellular platform for hematopoietic stem cell (HSC) culture. By seeding HSCs amongst MSC-laden hydrogel microspheres, they established paracrine-mediated interactions between HSCs and hydrogel encapsulated MSCs.

Mesenchymal Cell News covers topics such as the isolation, identification, and culturing conditions of mesenchymal stem cells, as well as their cellular characterization, behavior and differentiation capacities. We also include research that focuses on identifying tissue sources of mesenchymal stem cells and their potential therapeutic applications in regenerative medicine and cellular therapies.